In this issue of EuroIntervention

The 16th expert consensus from the European Bifurcation Club; ticagrelor or aspirin monotherapy 1 year after PCI; magnesium scaffolds in STEMI; the relationship between coronary vasospasm and atherosclerosis in ANOCA; lifetime valve journey with severe aortic stenosis; endovascular atherectomy in PAD; and more...including our new impact factor!

EuroIntervention 2022;18:e-e.

Davide Capodanno
Davide Capodanno
The new impact factor of EuroIntervention is 7.728, the highest in the history of our Journal and, for the first time, above the psychological threshold of 7. With that, the journal remains in the first quartile of cardiovascular journals, now occupying the second position worldwide among all interventional cardiology journals.

This year while waiting for the verdict (this year it arrived on June 28th) I considered, for a few minutes, the insane idea of writing an editorial with a positive tone in the event of a favourable impact factor (i.e., in this case higher than last year’s 6.534) and ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
The unsolved issue with limited evidence: antiplatelet therapy during the chronic maintenance period after percutaneous coronary intervention

Latest news